Dr. Gearóid Tuohy

ProQR Therapeutics N.V. (NASDAQ: PRQR), expects to enrol 36 patients of LCA10  using a novel therapy for “Sepofarsen” (QR-110)

A Dutch biotechnology company, ProQR Therapeutcis N.V., (NASDAQ:PRQR), Leiden, has announced the enrolment of a phase 2/3 study for the treatment of Leber Congenital Amaurosis… Read More »ProQR Therapeutics N.V. (NASDAQ: PRQR), expects to enrol 36 patients of LCA10  using a novel therapy for “Sepofarsen” (QR-110)

Surgical “pearls” point to valuable observations among 120 treatments using subretinal gene therapy for inherited retinal degenerations.   

Surgical “pearls” of research have been published in the journal, Retina (accessed January 18, 2021), following the completion of 120 subretinal surgeries, performed by a… Read More »Surgical “pearls” point to valuable observations among 120 treatments using subretinal gene therapy for inherited retinal degenerations.